ReviewClinical & translational immunology2020
Targeting Toll-like receptor-4 to tackle preterm birth and fetal inflammatory injury.
Sarah A Robertson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this paperpooled ittrialcites it